Company / Income Tax per Share
Neurocrine Biosciences Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$2.28
FY2025
5-year range
$0.13 / $2.28
FY2021-FY2025
Trend
+55.6%
vs FY2024
Sector context
#7 of 199
Health Care
What the data says
Among 199 Health Care companies, Neurocrine Biosciences is in the bottom 4% for income tax per share. Income Tax per Share has increased for 5 consecutive years, from $-3.26 in FY2020 to $2.28 in FY2025.
Based on SEC 10-K filings.
2.28 in FY2025 with a 3-year CAGR of +53.9%. Top quartile in the Health Care sector.
Increased from $0.85 to $2.28 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +53.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 199This company $2.28 Sector average $1.36
▼
+68.4% above sector average
Key checks
Key Insights
- Neurocrine Biosciences's income tax per share has grown for 5 consecutive years.
- In FY2025, income tax per share increased 55.6% year-over-year.
- Ranks #7 out of 199 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.28 | +55.6% |
| FY2024 | $1.47 | +71.7% |
| FY2023 | $0.85 | +36.4% |
| FY2022 | $0.63 | +396.0% |
| FY2021 | $0.13 | +103.9% |
| FY2020 | -$3.26 | -3212.7% |
| FY2019 | $0.10 | +1227.2% |
| FY2018 | $0.01 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026